Upgrade to SI Premium - Free Trial

Aerie Pharma (AERI): Raising PT On Roclatan Data - Needham

May 25, 2017 6:17 AM
Needham & Company analyst, Serge Belanger, reiterated his Buy rating on shares of Aerie Pharma (NASDAQ: AERI) and raised his ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles